These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12688391)

  • 1. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Ishii C
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S19-22. PubMed ID: 12688391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Horie H; Sugimoto Y; Kinoshita M
    J Am Coll Cardiol; 2000 Sep; 36(3):838-44. PubMed ID: 10987608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
    Feola M; Menardi E; Ribichini F; Vado A; Deorsola A; Ferrero V; Visconti G; Milanese U; Uslenghi E
    Med Sci Monit; 2003 Aug; 9(8):CR341-5. PubMed ID: 12942029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
    Wasywich CA; Webster MW; Richards AM; Stewart RA
    Am J Cardiol; 2006 Apr; 97(7):1068-72. PubMed ID: 16563918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.
    Tsutamoto T; Wada A; Sakai H; Ishikawa C; Tanaka T; Hayashi M; Fujii M; Yamamoto T; Dohke T; Ohnishi M; Takashima H; Kinoshita M; Horie M
    J Am Coll Cardiol; 2006 Feb; 47(3):582-6. PubMed ID: 16458140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy].
    Popovich MI; Zatushevskiĭ IF; Botnar' VI
    Ter Arkh; 1986; 58(11):65-7. PubMed ID: 3547749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
    Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
    Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
    Gao X; Peng L; Adhikari CM; Lin J; Zuo Z
    J Card Fail; 2007 Apr; 13(3):170-7. PubMed ID: 17448413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
    Rousseau MF; Gurné O; Duprez D; Van Mieghem W; Robert A; Ahn S; Galanti L; Ketelslegers JM;
    J Am Coll Cardiol; 2002 Nov; 40(9):1596-601. PubMed ID: 12427411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of microalbuminuria in chronic heart failure patients.
    van de Wal RM; Asselbergs FW; Plokker HW; Smilde TD; Lok D; van Veldhuisen DJ; van Gilst WH; Voors AA
    J Card Fail; 2005 Oct; 11(8):602-6. PubMed ID: 16230263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy of captopril and spironolactone for refractory congestive heart failure.
    Han YL; Tong M; Jing QM; Hu XL; Liu JQ
    Chin Med J (Engl); 1994 Sep; 107(9):688-92. PubMed ID: 7805462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
    Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Tsutsui T; Matsui T; Fujii M; Matsumoto T; Yamamoto T; Horie H; Ohnishi M; Kinoshita M
    J Am Coll Cardiol; 2001 Nov; 38(5):1375-82. PubMed ID: 11691511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.